In response to the letter to the editor by Soha Ghanian et al. re our publication "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"
- PMID: 34134089
- PMCID: PMC8197779
- DOI: 10.1016/j.ebiom.2021.103426
In response to the letter to the editor by Soha Ghanian et al. re our publication "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"
Conflict of interest statement
Declaration of Competing Interest The authors have no competing interests.
Comment on
-
Letter to the Editor re: Baldassarri et al., 2021 "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males".EBioMedicine. 2021 Jun;68:103425. doi: 10.1016/j.ebiom.2021.103425. Epub 2021 Jun 13. EBioMedicine. 2021. PMID: 34134086 Free PMC article. No abstract available.
References
-
- Cadegiani FA, McCoy J, Gustavo Wambier C, Goren A. Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and time-to-remission in males with COVID-19: a randomized, double-blind, placebo-controlled interventional trial (EAT-DUTA AndroCoV Trial - Biochemical) Cureus. 2021;13:e13047. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
